BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:40:00 PM | Browse: 946 | Download: 932
 |
Received |
|
2013-07-17 10:24 |
 |
Peer-Review Started |
|
2013-07-17 15:09 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2013-09-15 18:58 |
 |
Revised |
|
2013-10-13 01:26 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2013-11-04 17:58 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2013-11-05 10:08 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-11-20 09:22 |
 |
Publish the Manuscript Online |
|
2013-12-11 16:13 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Marija Zeremski, Jon E Zibbell, Anthony D Martinez, Steven Kritz, Bryce D Smith and Andrew H Talal |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Andrew H Talal, MD, MPH, Professor, Chief, Division of Gastroenterology, Hepatology and Nutrition, State University of New York at Buffalo, UB/CTRC, 875 Ellicott Street, Suite 6090, Buffalo, NY 14203, United States. ahtalal@buffalo.edu |
| Key Words |
Treatment of hepatitis C; Viral infection; Human immunodeficiency virus; Hepatitis C virus coinfection; Persons who inject drugs; Obstacles to treatment |
| Core Tip |
Despite persons who inject drugs (PWIDs) representing the majority of the hepatitis C virus (HCV) disease burden, few receive treatment for HCV. Barriers to treatment uptake exist at multiple levels. Co-localization of HCV management with substance abuse facilities may result in greater treatment uptake for PWID.
|
| Publish Date |
2013-12-11 16:13 |
| Citation |
Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol 2013; 19(44): 7846-7851 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i44/7846.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i44.7846 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345